[2020-2027] Advanced Wound Care Market to Exhibit a CAGR of 5.1% and Cross USD 15.59 Billion by 2027; Unmet Patient Needs to Incite Acceptance of Effective Therapies, states Fortune Business Insights™

    NEXT STORY
    Philips and Singapore General Hospital (SGH) to establish Digital and Computational Pathology Center of Excellence
    PREV STORY
    First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZeneca
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase 3 Clinical Trial

    LOS ANGELES, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter ...

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Announces Pricing of $25 Million Underwritten Offering

    TEL-AVIV, Israel and RALEIGH, N.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

    author_avatar
    NASDAQ Market News

    Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors

    author_avatar
    NASDAQ Market News